31 related articles for article (PubMed ID: 15899386)
1. Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women.
Mostaid MS; Mumu SB; Haque MA; Sharmin S; Jamiruddin MR; Sayedur Rahman GM; Reza HM
PLoS One; 2021; 16(12):e0261984. PubMed ID: 34962972
[TBL] [Abstract][Full Text] [Related]
2. Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review.
Yu M; Zhang Q; Zhao X
Front Oncol; 2022; 12():973077. PubMed ID: 36059664
[TBL] [Abstract][Full Text] [Related]
3.
Coelho A; Nogueira A; Soares S; Assis J; Pereira D; Bravo I; Catarino R; Medeiros R
Oncol Lett; 2018 May; 15(5):8165-8171. PubMed ID: 29731921
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor Alpha (-238 / -308) and TNFRII-VNTR (-322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians.
Zidi S; Stayoussef M; Zouidi F; Benali S; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2015 Apr; 21(2):339-45. PubMed ID: 25113639
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer.
Sousa H; Oliveira S; Santos AM; Catarino R; Moutinho J; Medeiros R
Tumour Biol; 2014 Mar; 35(3):2561-4. PubMed ID: 24197984
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G.
Oliveira S; Ribeiro J; Sousa H; Pinto D; Baldaque I; Medeiros R
Oncol Rep; 2012 Apr; 27(4):1188-92. PubMed ID: 22200742
[TBL] [Abstract][Full Text] [Related]
7. Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis.
Liu L; Yang X; Chen X; Kan T; Shen Y; Chen Z; Hu Z
Mol Biol Rep; 2012 Mar; 39(3):2683-8. PubMed ID: 21670964
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between p53 codon 72 polymorphism and anal cancer risk.
Contu SS; Agnes G; Damin AP; Contu PC; Rosito MA; Alexandre CO; Damin DC
World J Gastroenterol; 2009 Sep; 15(36):4566-70. PubMed ID: 19777616
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.
Hrstka R; Coates PJ; Vojtesek B
J Cell Mol Med; 2009 Mar; 13(3):440-53. PubMed ID: 19379143
[TBL] [Abstract][Full Text] [Related]
10. Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?
Sousa H; Santos AM; Pinto D; Medeiros R
Acta Med Port; 2011; 24(1):127-34. PubMed ID: 21672450
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives.
de Moura Gallo CV; Azevedo E Silva Mendonça G; de Moraes E; Olivier M; Hainaut P
Mutat Res; 2005 May; 589(3):192-207. PubMed ID: 15878142
[TBL] [Abstract][Full Text] [Related]
12. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
Santos AM; Sousa H; Catarino R; Pinto D; Pereira D; Vasconcelos A; Matos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jun; 159(2):143-7. PubMed ID: 15899386
[TBL] [Abstract][Full Text] [Related]
13. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
14. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
15. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
